Suchergebnisse - "Tsukada, Nobuhiro"

PubPharm (209)

1

Cytomegalovirus Reactivation During Elotuzumab Therapy in Patients with Multiple Myeloma

enthalten in: Acta haematologica | 2024

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +8

2

Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma

enthalten in: International journal of hematology | 2024

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +8

3

Prognostic value of the “dynamic” second revision of the international staging system (R2- ISS) in patients with multiple myeloma undergoing anti-CD38 antibody, carfilzomib, and dexamethasone therapy

enthalten in: ResearchSquare.com | 2024

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +10

4

Prototype and evaluation of automatic fingertip-blood-sampling system that uses fingertip blood-vessel images to determine puncture position

enthalten in: Medical engineering & physics | 2024

von Takenaka, K. | Oyamada, Y. | Kato, M. | +5

5

Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

enthalten in: Hematological oncology | 2024

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +8

6

Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma

enthalten in: ResearchSquare.com | 2024

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +8

7

Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2023

von Shimizu, H. | Najima, Y. | Kako, S. | +19

8

Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies

enthalten in: Annals of hematology | 2023

von Kikuchi, T. | Tsukada, N. | Kunisada, K. | +8

9

Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs

enthalten in: Haematologica | 2023

von Takamatsu, H. | Matsuda, T. | Mizuno, S. | +21

10

Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma

enthalten in: Cytotherapy | 2023

von Okada, Y. | Kimura, F. | Kurita, N. | +21

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]